Manish Goel
About Manish Goel
SEBI Registered Research Analyst • Chartered Accountant
377 Articles Published
Manish Goel is a Chartered Accountant, SEBI Registered Research Analyst, and founder of Manish Goel PMS. A full-time value investor since 2010, he has helped thousands of investors build long-term wealth through quality stock picking and disciplined fundamental analysis.
April 18, 2026
A complete 8-factor framework for analysing Indian cement stocks — capacity, region, EBITDA per tonne, balance sheet, and consolidation theme. Live data, no F&O noise, real multibagger hunting.
April 17, 2026
Stop valuing companies on volatile reported earnings. Master the five-step normalization framework that Warren Buffett, Bruce Greenwald, and Howard Marks all use — and see why Titan Biotech's consistent earnings power already passes the test.
April 17, 2026
Ken Fisher's Price-to-Sales (P/S) ratio is the valuation tool Indian investors must master when earnings are temporarily distorted. Complete framework: thresholds, pitfalls, quality filters, and how to triangulate P/S with P/E, P/B, EV/EBITDA and DCF — with Titan Biotech illustrating the Super Stock quality envelope.
April 17, 2026
Titan Biotech's FY25 board paid ₹4.56 Cr across 5 directors — on zero raises during a down year. We decode Section 197, the CEO-to-median ratio (20.84:1), and the four-point forensic checklist every Indian value investor must apply to small-cap governance.